The Emirates Drug Corporation has announced the adoption of the drug “Tolbrotinip” as the first oral medication of its kind globally to treat multiple progressive secondary sclerosis.
The UAE adopts the first oral medicine to treat “multiple, non -dependent sclerosis”
